3l17: Difference between revisions
From Proteopedia
Jump to navigationJump to search
New page: '''Unreleased structure''' The entry 3l17 is ON HOLD Authors: Wiesmann, C., Sutherlin, D.P., Sampath, D., Berry, M., Castanedo, G., Heffron, T., Zhu, B-Y., Lewis, C., Olivero, A. Descr... |
No edit summary |
||
| Line 3: | Line 3: | ||
The entry 3l17 is ON HOLD | The entry 3l17 is ON HOLD | ||
Authors: | Authors: Murray, J.M., Wiesmann, C. | ||
Description: Discovery of (thienopyrimidin-2-yl)aminopyrimidines as Potent, Selective, and Orally Available Pan-PI3-Kinase and Dual Pan-PI3-Kinase/mTOR Inhibitors for the Treatment of Cancer | Description: Discovery of (thienopyrimidin-2-yl)aminopyrimidines as Potent, Selective, and Orally Available Pan-PI3-Kinase and Dual Pan-PI3-Kinase/mTOR Inhibitors for the Treatment of Cancer | ||
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed Dec | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed Dec 23 09:25:26 2009'' | ||
